Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Michael A. Hawk"'
Autor:
Katherine A. B. Knostman, Brian M. Roche, Edward J. Wakayama, Michael A. Hawk, Zhenxu J. Ma, Kim Henderson, Carol L. Sabourin, Patrick J. Sabourin, Glenn D. Ritchie, Claire M. Matthews
Publikováno v:
International Journal of Toxicology. 35:604-615
The Food and Drug Administration Animal Rule requires evaluation of cardiovascular and central nervous system (CNS) effects of new therapeutics. To characterize an adult and juvenile mouse model, neurobehavioral and cardiovascular effects and patholo
Autor:
Tom Vinci, Michael K. Pugsley, Robert L. Hamlin, Craig R. Hassler, Michael A. Hawk, J. Wallery
Publikováno v:
Journal of pharmacological and toxicological methods. 87
Each year the Safety Pharmacology Society (SPS) recognizes an investigator who has had a marked impact upon the discipline. The 2016 recipient of the SPS Distinguished Service Award (DSA) was Dr. Craig R. Hassler. Dr. Hassler is one of the founding m
Autor:
Kevin Hanjora, Carolyn G. Fetzek, Herbert S. Bresler, William W. Muir, Patrick D. Ganzer, Michael A. Hawk, Robert L. Hamlin, Amy Zmarowski, Thomas Vinci
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 99:106595
Autor:
Tom Vinci, Robert L. Hamlin, Elizabeth A. Ramsuchit, Aaron S. Rajasuriyar, Michael A. Hawk, Carolyn G. Fetzek
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 93:126
Autor:
Bryce Visnick, Michael A. Hawk, Amy Zmarowski, Shawnda Armentrout, Robert L. Hamlin, Seth Reed, Thomas Vinci, Brandon Wood, John Kinzer
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 88:230
Autor:
Michael A. Hawk, Kevin Hanjora, Brandon Wood, Javelyn R. Evans, Amy Zmarowski, Shawnda Armentrout, Thomas Vinci
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 88:191
Autor:
Tom Vinci, Merrill R. Osheroff, Craig R. Hassler, Glenn D. Ritchie, David T. Pressburger, Michael A. Hawk, Brian L. Burback, Brian M. Roche
Publikováno v:
International journal of toxicology. 32
The objectives of these studies were to determine the cardiopulmonary effects of a single intramuscular administration of 1,1′-methylenebis[4-[(hydroxyimino)methyl]-pyridinium] dimethanesulfonate (MMB4 DMS) on dogs and on the central nervous system
Autor:
Seth Gibbs, Merrill R. Osheroff, Brian L. Burback, Dean J. Kobs, Claire R. Croutch, Michael A. Hawk, Jerry D. Johnson, S. Peter Hong
Publikováno v:
International journal of toxicology. 32
1,1′-Methylenebis[4-[(hydroxyimino)methyl]-pyridinium] (MMB4) dimethanesulfonate (DMS) is a bisquaternary pyridinium aldoxime that reactivates acetylcholinesterase inhibited by organophosphorus nerve agent. Time courses of MMB4 concentrations in pl
Autor:
Joseph E. Tomaszewski, Michael A. Hawk, Daphne Vasconcelos, Glenn D. Ritchie, Pramod S. Terse, Denise A. Contos, James O. Peggins, Jerry D. Johnson, Michael J. Ryan, Susan P. Perrine
Publikováno v:
Toxicologic pathology. 39(4)
ST-20 (sodium 2,2-dimethylbutyrate) is a potential therapeutic agent for treatment of β-thalassemia and sickle cell disease. A subchronic oral toxicity study was conducted in Sprague-Dawley rats (10/sex/dose) at gavage dosages of 0 (vehicle control)
Autor:
Steve Behringer, Tom Vinci, Katherine A. B. Knostman, Michael A. Hawk, Glenn D. Ritchie, Kim Henderson, Brian M. Roche
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 75:185